top of page


Austin, TX (July 20, 2009) - 

Astrotech Corporation (NASDAQ: ASTC) Chairman and Chief Executive Officer, Thomas B. Pickens III today issued the following statement regarding the 40th anniversary of the first moon landing by Apollo 11.


“The 40th anniversary of the moon landing reminds us of the ingenuity and technical excellence that have driven NASA and the American space program for the last half century. As we celebrate this historic triumph in NASA’s past, we are proud to be a part of NASA’s future as a leader of the International Space Station national lab pathfinder missions. The exploration vision started forty years ago continues today as Astrotech works towards developing products in space to enhance life on earth.”


About Astrotech Corporation


Astrotech is one of the first commercial space companies and remains a strong entrepreneurial leader in the aerospace industry. The Company serves our government and commercial satellite and spacecraft customers with our pre-launch services from our Astrotech Space Operations (ASO) subsidiary and incubates space technology businesses now having formed three companies; the 1st Detect Corporation, which is developing a breakthrough mini-mass spectrometer first developed for the International Space Station; Astrogenetix, Inc., which is producing biotech products in space and has recently developed a vaccine candidate for Salmonella; and AirWard Corporation, which is drawing on its space heritage of sending cargo to space by selling hazardous material containers for the airline industry.


Statements in this document may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the company's Securities & Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

bottom of page